Dr. Samuel Denmeade is the R. Dale Hughes Professor of Oncology and Urology at the Johns Hopkins University School of Medicine and Director of the Genitourinary Oncology Division for the Johns Hopkins Kimmel Cancer Center. He also has appointments in the Department of Pharmacology and Molecular Sciences and Department of Biomolecular Engineering. His areas of clinical expertise include bladder cancer, kidney cancer, prostate cancer and testicular cancer. Dr. Denmeade earned his M.D. from the Columbia College of Physicians and Surgeons of Columbia University. He completed his residency at the University of Chicago. He performed a fellowship in oncology at The Johns Hopkins Hospital and a fellowship in medical oncology at the Johns Hopkins University School of Medicine. His research interests include prostate cancer, bipolar androgen therapy, clinical trials and targeted drug development. Dr. Denmeade has published over 200 papers in the area of prostate cancer research. He has received extensive funding from the NIH, the Department of Defense Prostate Cancer Research Fund and the Prostate Cancer Foundation. He is the Editor-in-Chief of the medical journal The Prostate. Dr. Denmeade is rated as an Elite provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Hormone Replacement Therapy (HRT), and Prostatectomy.

Mohit Khera, M.D., M.B.A., M.P.H., Associate Professor, is the Director of the Laboratory for Andrology Research at McNair Medical Institute, Baylor College of Medicine. He is also the Medical Director of the Executive Health Program at Baylor. Dr. Khera is a Board-certified urologist specializing in male infertility, male and female sexual dysfunction, and declining testosterone levels in aging men. Dr. Khera's research focuses on the efficacy of botulinum toxin type A in treating Peyronie's disease as well as genetic and epigenetic studies on post-finasteride syndrome patients and testosterone replacement therapy. Dr. Khera is rated as an Elite provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Hypogonadism, Peyronie Disease, Erectile Dysfunction (ED), Hormone Replacement Therapy (HRT), and Prostatectomy.

Joann Manson is a primary care provider, practicing in Endocrinologist in Boston, Massachusetts. Dr. Manson is rated as an Elite provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Menopause, Type 2 Diabetes (T2D), Coronary Heart Disease, Hormone Replacement Therapy (HRT), and Tubal Ligation.

Dr. Mark Markowski is a medical oncologist at the Kimmel Cancer Center at Sibley Memorial Hospital, as well as an Associate Professor in the Department of Oncology at Johns Hopkins University School of Medicine. Dr. Markowski participates in multidisciplinary clinics at Sibley and The Johns Hopkins Hospital, and sees patients in the genitourinary clinics of both hospitals. Dr. Markowski treats numerous types of cancers, with a specialty in prostate and kidney cancers. Dr. Markowski earned his medical degree and Ph.D. in tumor biology at Georgetown University School of Medicine. He completed a residency in internal medicine at Columbia University, followed by a medical oncology fellowship at Johns Hopkins Hospital. Dr. Markowski previously served as a research associate at the Lombardi Comprehensive Cancer Center at Georgetown University. His research interests focus on early phase drug development for prostate cancer, as well a non-castrating therapies for patients with metastatic disease. Dr. Markowski is currently conducting research with funding from a Department of Defense Prostate Cancer Research Program Award and a Challenge Award from the Prostate Cancer Foundation, which focuses on new treatment strategies for prostate cancer patients. Dr. Markowski is rated as an Elite provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Wilms Tumor 2, Hormone Replacement Therapy (HRT), and Prostatectomy.

Randall Urban is an Endocrinologist in Galveston, Texas. Dr. Urban has been practicing medicine for over 44 years and is rated as an Elite provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Hypopituitarism, Sheehan Syndrome, Hypogonadism, Hormone Replacement Therapy (HRT), and Orchiectomy.

Shalender Bhasin is an Endocrinologist in Boston, Massachusetts. Dr. Bhasin is rated as an Elite provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Hypogonadism, Isolated Hypogonadotropic Hypogonadism, Low Testosterone, Hormone Replacement Therapy (HRT), and Orchiectomy.

Cynthia Stuenkel is an Endocrinologist in San Diego, California. Dr. Stuenkel is rated as an Elite provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Menopause, Ovarian Overproduction of Androgens, Postmenopausal Osteoporosis, Amenorrhea, and Hormone Replacement Therapy (HRT).

Larry I. Lipshultz, M.D., is Professor of Urology and Chief of the Scott Department of Urology’s Division of Male Reproductive Medicine and Surgery. Dr. Lipshultz, who holds the Smith Chair in Reproductive Medicine, is a well-known authority on abnormalities of male reproduction, erectile dysfunction, and male hormone production. He received his medical training at the University of Pennsylvania and received fellowship training at the University of Texas at Houston as the first AUA research scholar. Recognized as a leading expert on men’s health, Dr. Lipshultz is a highly respected author and editor, as well as lecturer. Teacher as well as physician, researcher, writer, and editor, Dr. Lipshultz instituted a fellowship training program in male reproductive medicine and surgery that has trained more than 80 physicians who are now in practice both here and abroad. Dr. Lipshultz is rated as an Elite provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Peyronie Disease, Hypogonadism, Infertility, Vasectomy, and Hormone Replacement Therapy (HRT).

Taylor Kohn is a Urologist in Sugar Land, Texas. Dr. Kohn is rated as an Elite provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Erectile Dysfunction (ED), Hypogonadism, Partial Deletion of Y, Hormone Replacement Therapy (HRT), and Vasectomy.

Andrew Kaunitz is an Obstetrics and Gynecologist in Jacksonville, Florida. Dr. Kaunitz is rated as an Elite provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Menopause, Menorrhagia, Newborn Low Blood Sugar, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy. Dr. Kaunitz is currently accepting new patients.

Dr. Channing J. Paller is a medical oncologist at Sibley Memorial Hospital and a professor of oncology at the Johns Hopkins University School of Medicine. She practices out of the Prostate Cancer Multidisciplinary Clinic at Sibley Memorial Hospital in Washington, D.C., and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, MD. Dr. Paller has expertise in prostate, bladder, kidney, and testicular cancer. Dr. Paller earned her medical degree from Harvard Medical School and completed a residency in internal medicine, followed by a fellowship in hematology and oncology at Johns Hopkins University School of Medicine. In addition, Dr. Paller completed a rotation with the chief of the Investigational Drug Branch at the National Cancer Institute (NCI) Cancer Therapy Evaluation Program and a rotation with the associate director for regulatory science in the Office of Oncology Drug Products at the Food and Drug Administration. She also completed rotations at the Weizmann Institute of Israel’s Department of Biological Regulation and McCord Hospital in South Africa, where she participated in the Harvard AIDS project. In 2016, Dr. Paller was one of only five oncologists awarded the NCI Mentored Patient-Oriented Research Career Development Award. In 2015, she received the 2015 Passano Clinician Scientist Award for early-stage research that is already making a contribution to science. Earlier in her career, she was selected for both a 2011-2012 Young Investigator Award by the American Society of Clinical Oncology and for the 2011-12 Eastern Cooperative Oncology Group Paul Carbone Award. Dr. Paller is a member of the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Paller’s research focuses on evaluating new therapies for prostate cancer, particularly combination therapies that engage the immune system. She is the principal investigator on two multi-site clinical trials and was the first author on the NCI Investigational Drug Steering Committee publication, “Consensus Recommendations on the Phase I Combination Clinical Trials of the Clinical Trial Design Task Force.” Dr. Paller was the chair for the oral abstract session on genitourinary cancer at the 2015 Annual Meeting of the American Society of Clinical Oncology and she is currently funded by an NCI immunotherapy grant to look at combination therapies that link standard of care therapy with inhibition of transforming growth factor beta in prostate cancer. She is also opening trials of vitamin C with chemotherapy in prostate cancer and of mistletoe in all solid tumors. Dr. Paller is rated as an Elite provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Hormone Replacement Therapy (HRT), and Prostatectomy.

Anne Gompel practices in Paris, France. Ms. Gompel is rated as an Elite expert by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Menopause, Angioedema, Hereditary Angioedema, Hives, and Hormone Replacement Therapy (HRT).

Lauren Arditti is an Obstetrics and Gynecologist in Fort Worth, Texas. Dr. Arditti is rated as an Advanced provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Amenorrhea, Preeclampsia, Fetal Enterovirus Syndrome, Hormone Replacement Therapy (HRT), and Intrauterine Device Insertion.

David Bierer is an Obstetrics and Gynecologist in South Ogden, Utah. Dr. Bierer is rated as an Advanced provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Menopause, Menorrhagia, Premenstrual Syndrome, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy. Dr. Bierer is currently accepting new patients.

Dr. Marianne Ebrahim comes from a family of physicians and knew at an early age that she wanted to follow a similar path. The Dallas native is a board-certified obstetrician and gynecologist. She began her career in 2014 at the esteemed Cedars-Sinai Medical Center in Los Angeles, Calif., before returning to North Texas in 2019. From the first birth she witnessed, Dr. Ebrahim knew her purpose was to serve women throughout their lives. She is a D Magazine Best Doctors honoree with a history of high patient satisfaction for delivering quality maternity care and prevention-based services. Dr. Ebrahim obtained her medical degree from the Texas Tech University Health Science Center in Lubbock. She completed her OB/GYN residency at John Peter Smith Hospital in Fort Worth. She is multilingual in the languages of English, Spanish and Arabic. Away from the office, Dr. Ebrahim and her husband enjoy raising their three sons. Dr. Ebrahim is rated as an Advanced provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Amenorrhea, Solitary Fibrous Tumor, Carney Complex, Hormone Replacement Therapy (HRT), and Intrauterine Device Insertion.

Dr. Timothy Kremer has cultivated a career of service and leadership in the field of women’s health dating back to 2006. He began his career as a board-certified obstetrician-gynecologist working in a community hospital in Fort Worth. He previously served as founding program director for a hospital-based Obstetrics and Gynecology Residency Program in Arlington. Dr. Kremer is certified in the use of robotic-assisted approaches to gynecologic surgeries for hysterectomy, abnormal uterine bleeding, pelvic masses and more. His comprehensive philosophy of care also includes a focus on the treatment of diabetes, hypertension and other chronic conditions in pregnancy. Dr. Kremer frequents the area Top Doctors lists for his commitment to advancing women’s health and education in the field of OB-GYN. He has served on and chaired numerous committees during his medical career and is active in the Association of Professors in Gynecology and Obstetrics, the Tarrant County Medical Association and the Texas Association of Obstetrics and Gynecology. Additionally, he is a Diplomate of the American Board of Obstetrics and Gynecology and a Fellow of the American College of Obstetrics and Gynecology.Dr. Kremer earned his medical degree from the University of Cincinnati College of Medicine in Ohio. He completed his OB-GYN residency through the John Peter Smith Health Network in Fort Worth, Texas. Dr. Kremer is rated as an Advanced provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Vaginal Bleeding Between Periods, Amenorrhea, Uterine Fibroids, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy.

Dr. Kavitha Blewett is a New York native who largely grew up in the Plano, Texas, area. She has served the health care needs of North Texas women since 2004 as a board-certified obstetrician and gynecologist. Dr. Blewett is especially passionate about being a partner to her patients throughout their lives and health stages. In 2024, she became a D Magazine Best Doctor honoree for the seventh time in her extensive medical career, recognized for her caring bedside manner and educational approach to care. Dr. Blewett graduated with her medical degree from Albany Medical College in New York. She completed her OB/GYN residency at The University of Texas Southwestern Medical Center-Parkland Hospital in Dallas. Dr. Blewett is married and has two daughters. Dr. Blewett is rated as an Advanced provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Amenorrhea, Solitary Fibrous Tumor, Carney Complex, Hormone Replacement Therapy (HRT), and Hysterectomy.

Dr. Tina Thai was born and raised in Texas, spending much of her early years in the Austin area before starting her undergraduate studies in Killeen, Texas. She later earned her medical degree at the University of North Texas Health Science Center - Texas College of Osteopathic Medicine in Fort Worth. She completed her Ob/Gyn residency at Texas Tech University Health Science Center Permian Basin in Odessa, where she was chief resident in her final year of training. Dr. Thai has served the women’s care needs of the Plano community since 2021. She evaluates and manages a broad range of obstetrical and gynecological concerns and is skilled in minimally invasive surgical techniques, including robotic-assisted surgeries. Dr. Thai is a member of the American Congress of Obstetricians & Gynecologists and American Medical Association. When not with her patients, she enjoys spending time with her husband and fur baby, Buddy, playing tennis, and doing arts and crafts projects. Dr. Thai is a Fellow of the American College of Obstetricians and Gynecologists. She is also a member of the American Congress of Obstetricians & Gynecologists and American Medical Association. Dr. Thai is rated as an Advanced provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Solitary Fibrous Tumor, Carney Complex, Intestinal Leiomyoma, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy.

Omar Cabrera is an Obstetrics and Gynecologist in Stephenville, Texas. Dr. Cabrera is rated as an Advanced provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Vaginal Bleeding Between Periods, Polycystic Ovary Syndrome, Infertility, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy.

Farid Saad practices in Leverkusen, Germany. Mr. Saad is rated as an Elite expert by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Hypogonadism, Metabolic Syndrome, Obesity, Isolated Hypogonadotropic Hypogonadism, and Hormone Replacement Therapy (HRT).